Compass Therapeutics (CMPX) Other Working Capital Changes (2021 - 2026)
Compass Therapeutics (CMPX) reported Other Working Capital Changes of -$38000.0 for Q1 2026, up 84.98% on a YoY basis from -$20542.7 in Q1 2025, and little changed sequentially from -$38000.0 in Q4 2025.
Compass Therapeutics (CMPX) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Compass Therapeutics (CMPX) has 6 years of Other Working Capital Changes data on file, last reported at -$38000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 84.98% year-over-year to -$38000.0; the trailing twelve-month figure through Mar 2026 stood at -$154000.0 (up 86.61% YoY), and the FY2025 full-year result was -$369000.0, up 69.68% from the prior year.
- Other Working Capital Changes was little changed at -$38000.0 in Q1 2026, from -$38000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $6.2 million in Q4 2022 to a low of -$6.3 million in Q2 2025.
- A 5-year average of -$79000.0 and a median of -$312000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes soared 101.66% in 2024 and slumped 840.0% in 2025, its largest moves.
- Tracing CMPX's Other Working Capital Changes over 5 years: stood at -$284000.0 in 2022, then retreated by 9.15% to -$310000.0 in 2023, then tumbled by 86.13% to -$577000.0 in 2024, then soared by 93.41% to -$38000.0 in 2025, then changed by 0.0% to -$38000.0 in 2026.
- Business Quant data shows CMPX's Other Working Capital Changes at -$38000.0 in Q1 2026, -$38000.0 in Q4 2025, and -$37000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Compass Therapeutics | 395.17 Mn | 200.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38,000.00 |
| Mar 31, 2026 | -38,000.00 |
| Mar 31, 2026 | -38,000.00 |
| Dec 31, 2025 | -38,000.00 |
| Dec 31, 2025 | -38,000.00 |
| Dec 31, 2025 | -38,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -41,000.00 |
| Jun 30, 2025 | -41,000.00 |
| Jun 30, 2025 | -41,000.00 |
| Mar 31, 2025 | -253,000.00 |
| Mar 31, 2025 | -253,000.00 |
| Mar 31, 2025 | -253,000.00 |
| Dec 31, 2024 | -577,000.00 |
| Dec 31, 2024 | -577,000.00 |
| Dec 31, 2024 | -577,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |